{"metadata": {"organization_names": ["mallinckrodt inc"], "person_names_verified": ["marie berry", "tom palmer"], "organization_names_verified": ["mallinckrodt inc", "amylin pharmaceuticals inc", "amylin pharmaceuticals, inc.", "mallinckrodt inc."], "topics": [], "entities_rejected": [], "person_names": ["mcdonnell blvd"], "agreement_id": "efa54b45b21070ca2ddc7d1361195940e2d4ebe3d8e2fe110a57b1fc5199951d", "vars": {}, "terms": ["***", "***** Confidential Treatment Requested**", "*****Text Omitted and Filed Separately with the Securities and Exchange**", "***] ([***", "**AMYLIN PHARMACEUTICALS, INC.**", "**Commission. Confidential Treatment Requested Under**", "**EXENATIDE DRUG SUBSTANCE**", "**EXHIBIT A**", "**MALLINCKRODT INC., a Covidien company**", "**[***", "**[Forecast Attached]**", "\u201cAgreement\u201d", "\u201cAmylin\u201d", "\u201cMallinckrodt\u201d"]}}